Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
about
BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH)The etiologic spectrum of head and neck squamous cell carcinoma in young patientsHPV in oropharyngeal cancer: the basics to know in clinical practiceTherapeutic insights from genomic studies of head and neck squamous cell carcinomasAnimal models to study the mutational landscape for oral cavity and oropharyngeal cancersPredictive value of epigenetic alterations in head and neck squamous cell carcinomaHuman papillomavirus and survival of patients with oropharyngeal cancer.HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.Genome stability pathways in head and neck cancersCGHregions: dimension reduction for array CGH data with minimal information lossGenomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck.CGHpower: exploring sample size calculations for chromosomal copy number experiments.Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.Clinical update on cancer: molecular oncology of head and neck cancerAdvances in the management of squamous cell carcinoma of the head and neck.High-resolution genomic profiling of human papillomavirus-associated vulval neoplasia.Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.Integrative molecular characterization of head and neck cancer cell model genomesImmortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways.Deciphering squamous cell carcinoma using multidimensional genomic approaches.Impact of HPV in Oropharyngeal Cancer.Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomasIdentification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53Genome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival.Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancerClinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesIntegrated genomics approach to identify biologically relevant alterations in fewer samplesHuman papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implicationsGenetic Landscape of Human Papillomavirus-Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors.Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients.Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinomaThe transcription factor CREBZF is a novel positive regulator of p53.Clinical implications of human papillomavirus in head and neck cancers.Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer.MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma.Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.
P2860
Q25257750-EABA0452-813F-4659-82ED-D2F2D8F6B401Q26741362-A49893FE-C67E-4FD8-87AE-810194EC8A00Q26853669-0CB8DAAC-43F8-43A6-9585-795937FDD4B4Q27006854-4C2584CE-AE94-4CE2-A080-395C54FB6AF3Q27026169-EDE7AB1A-CE7A-4B1C-8EFD-75D9DEE25622Q27690755-8B63FEE0-641A-4EA9-A806-F8BD8C2D3458Q27851567-F456EDFD-1A80-4022-AE2C-2E0C8EB091BAQ27852254-C2C7EED6-7DDE-4C32-8CC0-29C40573DFC2Q28391355-1C10623D-905D-412D-8118-D9AE6CF5AA3EQ33448540-97798C20-CF37-4BC9-A316-6A2FF963ECD7Q33457679-7FA34FF7-29C6-46CE-87B2-8FE08089AD9BQ33610832-0E5A0639-555A-4F75-9D16-29C231E46948Q33637161-07C52999-4546-4526-8D1C-C21DF3D6C050Q33695197-9B8191F8-0F41-420D-9436-0C1C1B7C0658Q33720431-A8153ED0-C3CC-41C7-8E76-AF83431B7CE5Q33747413-F429E4AB-10EA-45BC-9DF5-F4C08A278F15Q33770030-94C13A32-F10F-49AE-9417-0A3AE4BEC056Q33798848-9CC2C176-EA12-4AF1-B3FC-D6061E43D8FDQ34091528-8638B93A-409B-4024-A765-221FE8980CD6Q34117301-F00795BD-5265-449C-B1E0-49B58861DF4AQ34475613-0E39515B-B823-4779-AA6F-37883D0A9663Q34479115-41C82C4E-1752-4C2D-A32C-97CB5C6C6D6BQ34622885-A12691A4-A5E7-40BD-9783-DDE2C6CD0E82Q35080500-5B930526-2EE9-4D36-BFF5-1FA5010DE572Q35475401-357295AA-85B3-4F35-9938-DACAC085D42AQ35738663-C315A463-BEC2-40A9-882C-66D790D7B323Q35818215-D7BAA442-AD85-48B6-92AC-2C99C15F1B3BQ35821098-DE72199B-57EE-46DE-A85D-0ABCDC808820Q35833553-0368DAAB-3D17-43FD-B05F-83A1F958C514Q35838231-DB169DB2-3121-4B7B-ABD9-FF2C903693A2Q35842440-D0091FD9-C624-4D57-93AF-D7A20724B093Q35866493-83A248EC-F806-4AB2-8833-BA0033484AC6Q36100833-B6F2EA09-25B4-4B2F-9552-A45A34EB3F21Q36190032-BBE022C8-4A2C-4267-AE26-B8A586A5ABC4Q36201478-6C1BCFDE-870D-43D4-8C23-9D515A83F7FDQ36392179-7450A3A0-BD6D-4E1E-8E67-3E3987F720FAQ36416436-FA121867-0A39-491C-9E8F-04E30ADED66CQ36529848-A91B00D2-31DE-46CA-8657-CFE9D401A995Q36605100-95F5A21C-9165-45F6-A30E-7ED7C7EFB332Q36639572-53AF8E40-0747-4A49-9FE6-12AD5F115D24
P2860
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Genome-wide DNA copy number al ...... pressing human papillomavirus.
@en
Genome-wide DNA copy number al ...... pressing human papillomavirus.
@nl
type
label
Genome-wide DNA copy number al ...... pressing human papillomavirus.
@en
Genome-wide DNA copy number al ...... pressing human papillomavirus.
@nl
prefLabel
Genome-wide DNA copy number al ...... pressing human papillomavirus.
@en
Genome-wide DNA copy number al ...... pressing human papillomavirus.
@nl
P2093
P356
P1433
P1476
Genome-wide DNA copy number al ...... pressing human papillomavirus.
@en
P2093
Braakhuis BJ
Brakenhoff RH
Leemans CR
Snijders PJ
van de Wiel MA
P2888
P304
P356
10.1038/SJ.ONC.1209275
P407
P50
P577
2006-04-01T00:00:00Z
P5875
P6179
1027620720